Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tassone

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Current Cancer Drug Targets|June 8, 2012
Mouse models as a translational platform for the development of new therapeutic agents in multiple myelomaP Tassone, P Neri, R Burger, et al.
Current Cancer Drug Targets|June 8, 2012
Promises and challenges of MicroRNA-based treatment of multiple myelomaP Tagliaferri, M Rossi, M T Di Martino, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 22, 2017
Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC-MS/MSS Franzoni, A Vezzelli, A Turtoro, et al.
Blood Cancer Journal|December 17, 2016
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survivalC Botta, M T Di Martino, D Ciliberto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2007
Pegylated liposomal doxorubicin is active in Stewart-Treves syndromeP Tassone, P Tagliaferri, I Cucinotto, et al.
Tissue Antigens|April 1, 1995
Detection of an antigenic marker expressed by peripheral blood monocytes and platelets by a new monoclonal antibody, UN8P Tassone, P Bonelli, F Tuccillo, et al.
International Journal of Immunopathology and Pharmacology|December 21, 2013
Ink spot lentigo: singular clinical features in a case series of patientsU Bottoni, S Nisticò, G F Amoruso, et al.
Human Mutation|February 12, 2000
Hereditary nonpolyposis coloretal cancer: identification of novel germline mutations in two kindreds not fulfulling the Amsterdam criteria. Mutations in brief no. 203. OnlineB Quaresima, C Grandinetti, F Baudi, et al.
Journal of Biochemistry|July 19, 2003
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cellsM Caraglia, M Marra, G Giuberti, et al.
British Journal of Cancer|June 25, 2014
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancerY-K Kang, S Y Rha, P Tassone, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Current Cancer Drug Targets|June 8, 2012
Mouse models as a translational platform for the development of new therapeutic agents in multiple myelomaP Tassone, P Neri, R Burger, et al.
Current Cancer Drug Targets|June 8, 2012
Promises and challenges of MicroRNA-based treatment of multiple myelomaP Tagliaferri, M Rossi, M T Di Martino, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 22, 2017
Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC-MS/MSS Franzoni, A Vezzelli, A Turtoro, et al.
Blood Cancer Journal|December 17, 2016
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survivalC Botta, M T Di Martino, D Ciliberto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2007
Pegylated liposomal doxorubicin is active in Stewart-Treves syndromeP Tassone, P Tagliaferri, I Cucinotto, et al.
Tissue Antigens|April 1, 1995
Detection of an antigenic marker expressed by peripheral blood monocytes and platelets by a new monoclonal antibody, UN8P Tassone, P Bonelli, F Tuccillo, et al.
International Journal of Immunopathology and Pharmacology|December 21, 2013
Ink spot lentigo: singular clinical features in a case series of patientsU Bottoni, S Nisticò, G F Amoruso, et al.
Human Mutation|February 12, 2000
Hereditary nonpolyposis coloretal cancer: identification of novel germline mutations in two kindreds not fulfulling the Amsterdam criteria. Mutations in brief no. 203. OnlineB Quaresima, C Grandinetti, F Baudi, et al.
Journal of Biochemistry|July 19, 2003
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cellsM Caraglia, M Marra, G Giuberti, et al.
British Journal of Cancer|June 25, 2014
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancerY-K Kang, S Y Rha, P Tassone, et al.
Pageof 9